Clin2
NCT07011953Possibly a fitNot yet recruiting

Thyroid hormone for lack of motivation in schizophrenia

SchizophreniaAvolition

Part of Mental health clinical trials.

This trial tests whether adding a thyroid hormone called thyroxine to your usual medication can help with lack of motivation, a common symptom in schizophrenia. You would need to be stable on your current antipsychotic and not have any thyroid problems.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
90 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You have a diagnosis of schizophrenia and are between 18 and 45 years old.
  • You are right-handed.
  • Your symptoms are stable with the same antipsychotic medication dose for at least 4 weeks.
  • You have significant lack of motivation but mild positive symptoms (like hallucinations or delusions).
  • You are not taking clozapine or first-generation antipsychotics, and do not have thyroid disease.
  • You can have an MRI scan (no metal implants or claustrophobia).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05778591Recruiting· Phase 2
Low-dose buprenorphine to improve social drive in schizophrenia

This study tests whether low-dose buprenorphine can improve social motivation in people with schizophrenia. It compares social motivation changes while keeping participants stable on treatment and avoiding certain medicines and substances.

Los Angeles, California
NCT05805397Recruiting
Motivation skills training for schizophrenia or schizoaffective disorder

This study tests whether “Motivation Skills Training” can help people with schizophrenia or schizoaffective disorder. It’s for people who are stable on treatment and can participate in English-speaking sessions.

New York, New York
NCT07586150Not yet recruiting
Personalized Treatment for Serious Mental Illness

This study tests whether combining medicine adjustments, lifestyle changes (like diet and exercise), and optional brain stimulation can help people with schizophrenia, bipolar disorder, or depression feel better and function more independently. It may include a weight-loss medication if you're overweight or obese.

Vienna
NCT07424183Not yet recruiting· Phase 2
T4/T3 combination therapy for hypothyroidism symptoms

This trial tests if adding a second thyroid hormone (T3) to standard levothyroxine (T4) can better relieve persistent hypothyroidism symptoms like fatigue or brain fog. You may qualify if you still have symptoms despite being on a stable dose of levothyroxine.

Philadelphia, Pennsylvania
NCT06731764Recruiting· Phase 2/Phase 3
New ways to treat hypothyroidism

This study tests a new approach for people with hypothyroidism who are already taking levothyroxine. You may be able to join if you are on a certain dose and do not have other health conditions that could affect the results.

Farmington, Connecticut
NCT07332273Recruiting· Phase 3
Levothyroxine for weight loss in obesity

This trial tests whether adding levothyroxine (a thyroid hormone) to a low-calorie diet helps people with obesity lose more weight. It is for adults aged 25-60 with a BMI of 30-39.9 who have either mild underactive thyroid or normal thyroid but higher thyroid hormone levels in the normal range.

Cadiz

Hear when a new Schizophrenia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.